Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 15 - Drugs for genital or sexual disorders; Contraceptives
Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
10/2001
10/10/2001EP1140889A2 Compounds and methods for modulation of estrogen receptors
10/10/2001EP1140882A1 Piperazine ethylamide derivatives with 5-ht1a receptor activity
10/10/2001EP1140876A1 Morpholinone and morpholine derivatives and uses thereof
10/10/2001EP1140867A1 New beta-amide and beta-sulfonamide carboxylic acid derivatives, their preparation and their use as endothelin receptor antagonists
10/10/2001EP1140848A2 Phenethyl-5-bromopyridylthiourea (pbt) and dihydroalkoxybenzyloxopyrimidine (dabo) derivatives exhibiting spermicidal activity
10/10/2001EP1140838A1 1, 4-piperazine derivatives having 5ht1a receptor activity
10/10/2001EP1140835A1 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
10/10/2001EP1140831A1 Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine urea derivatives having 5ht1a receptor activity
10/10/2001EP1140828A1 3-azabicyclo[3.1.0]hexane derivatives as opiate receptors ligands
10/10/2001EP1140784A2 Ion channel modulating agents
10/10/2001EP1140194A2 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combined treatment of neoplasia
10/10/2001EP1140193A2 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
10/10/2001EP1140192A2 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia
10/10/2001EP1140183A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia
10/10/2001EP1140182A2 Use of a matrix metalloproteinase inhibitor together with an antineoplastic agent, optionally also together with radiation, in the treatment of neoplasia
10/10/2001EP1140179A2 Use of a cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia
10/10/2001EP1140178A2 Use of a matrix metallaproteinase inhibitor and radiation as a combined treatment of neoplasia
10/10/2001EP1140177A2 Use of an integrin antagonist and radiation in the treatment of neoplasia
10/10/2001EP1140160A2 Method for producing autogenous vaccines for treating chlamydial infections in mammals and humans
10/10/2001EP1140151A2 Compositions and methods for reducing or preventing fertilization in fish and birds
10/10/2001EP1140132A1 Gonadotropin releasing hormone antagonist
10/10/2001EP1140118A1 Cyclic adenosine diphosphate ribose analogues for modulating t cell activity
10/10/2001EP1140113A2 Use of bisphosphonates for the prevention and treatment of infectious processes
10/10/2001EP1140110A2 Clathrates of dehydroepiandrosterone and corresponding pharmaceutical compositions
10/10/2001EP1140109A1 Triphasic oral contraceptive
10/10/2001EP1140108A1 Method and composition for treatment of female sexual dysfunction
10/10/2001EP1140102A2 Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
10/10/2001EP1140101A1 Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
10/10/2001EP1140094A1 Use of apomorphine in the manufacture of a medicament for the treatment of organic erectile dysfunction in males
10/10/2001EP1140092A2 Method of treating sexual disturbances
10/10/2001EP1140091A2 Formulations comprising imiquimod or other immune response modifiers for treating mucosal consitions
10/10/2001EP1140048A2 Methods for treating certain diseases using naaladase inhibitors
10/10/2001EP1140044A2 cGMP PDE 5 INHIBITORS FOR INHALATION IN THE TREATMENT OF SEXUAL DYSFUNCTION
10/10/2001EP1140038A1 Transdermal drug delivery system
10/10/2001EP1140027A1 Dosage forms comprising porous particles
10/10/2001EP1139913A1 Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents
10/10/2001CN1317005A Substituted pyrazole derivatives condensed with six-membered heterocyclic rings
10/10/2001CN1316993A 4,4-biarylpiperidime derivatives with opioid receptor activity
10/10/2001CN1316906A Stable liquid formulations of botulinum toxin
10/10/2001CN1316260A Medicine for treating impotence
10/10/2001CN1072678C Trifluoro-methyl steroid, preparation and its application
10/10/2001CN1072666C (Azetidin-1-ylalkyl) lactams as tachykinin antagonists
10/10/2001CN1072647C Novel inhibitors of bone reabsorption and antagonists of vitronectin receptors
10/09/2001US6300499 α1-adrenergic receptor antagonists
10/09/2001US6300335 Urogenital disorders
10/09/2001US6300311 Administering epidermal growth factor to pigs to increase litter size
10/07/2001CA2304906A1 13-hode, a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
10/04/2001WO2001073034A2 Beta-like glycoprotein hormone polypeptide and heterodimer
10/04/2001WO2001073033A2 Anti-angiogenic and anti-tumor properties of matin and other laminin domains
10/04/2001WO2001073029A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
10/04/2001WO2001073025A2 Anti-angiogenic and anti-tumor properties of vascostatin and other nidogen domains
10/04/2001WO2001072960A2 Il-8 receptor antagonists
10/04/2001WO2001072839A2 Human g-protein coupled receptors
10/04/2001WO2001072831A2 Immunoregulator
10/04/2001WO2001072778A2 Method of identifying inhibitors of tie-2
10/04/2001WO2001072777A2 Human transcription factors
10/04/2001WO2001072772A2 Calcium binding regulatory subunit
10/04/2001WO2001072767A1 Dehydroepiandrosterone derivatives, preparation method and uses thereof, in particular for cosmetics
10/04/2001WO2001072752A2 2,3,4,5-TETRAHYDRO-1H-[1,4]DIAZEPINO[1,7-a]INDOLE COMPOUNDS
10/04/2001WO2001072713A1 Non-steroidal, tetracyclic compounds for estrogen-related treatments
10/04/2001WO2001072711A1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
10/04/2001WO2001072705A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors
10/04/2001WO2001072703A1 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors
10/04/2001WO2001072702A2 Amidino compounds useful as nitric oxide synthase inhibitors
10/04/2001WO2001072687A1 Diphenyl ether compounds useful in therapy
10/04/2001WO2001072301A1 Intracorporeal medicaments for photodynamic treatment of disease
10/04/2001WO2001072293A2 Antiprogestins with partial agonist activity
10/04/2001WO2001072281A2 Microspheres for active embolization
10/04/2001WO2001046144A8 New modulators of dopamine neurotransmission
10/04/2001WO2001019828A3 Kinase inhibitors as therapeutic agents
10/04/2001WO2001019361A3 Therapeutic uses of polymers and oligomers comprising gamma-hydroxybutyrate
10/04/2001WO2001000244A3 METHODS OF TREATMENT USING ANTI-ErbB ANTIBODY-MAYTANSINOID CONJUGATES
10/04/2001WO2000039279A9 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
10/04/2001US20010027216 Method for preventing hormone induced adverse effects
10/04/2001US20010027197 Antiproliverative, -carcinogenic and -tumor agents; mitogenesis-activated protein kinase inhibitors; noncytotoxic; binding with high affinity at the adenosine triphosphate binding site of the kinases
10/04/2001US20010027184 Serine/threonine protein kinase (H-SGK2)
10/04/2001US20010026794 Two heterologous DNA encoding gene products; prolonged half-life
10/04/2001EP1138692A1 Fragments of human chorionic gonadotropin (hcg) as immunoregulator
10/04/2001EP1138690A1 A process for the isolation of 2-deoxy ecdysterone from Zoanthus sp and its use for the preparation of a medicament for inducing labour or abortion
10/04/2001EP1138674A1 Crystalline forms of 3-(2,4-dichlorobenzyl)-2-methyl-n-(pentylsulfonyl)-3h-benzimidazole-5-carboxamide
10/04/2001EP1138329A2 Composition containing 5-Methyl-1-phenyl-2-(1 H)-pyridone for reparation and prevention of fibrotic lesions
10/04/2001EP1137772A1 Spermatogenesis protein
10/04/2001EP1137423A2 Oral administration of lactobacillus for the treatment and prevention of urogenital infection
10/04/2001EP1137420A1 Method for obtaining and using a combination of a purine and a nitrogen monoxide donor for preventing or treating sexual dysfunction
10/04/2001EP1137414A1 Use of acetylcholinesterase inhibitors on the modulation of the hypothalamic-pituitary-gonadal axis
10/04/2001EP1137409A2 Compositions and methods for amelioration of human female sexual dysfunction
10/04/2001EP1137408A1 Agent for lowering endothelin levels
10/04/2001EP0668876B1 Treatment of infertility and enhancement of fertilization capacity in mammalian males by thymosin peptide and its antibodies
10/04/2001EP0613465B1 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents
10/04/2001DE19947154A1 Substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use
10/04/2001CA2404662A1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
10/04/2001CA2404532A1 Method of identifying inhibitors of tie-2
10/04/2001CA2404496A1 Calcium binding regulatory subunit
10/04/2001CA2404461A1 Human g-protein coupled receptors
10/04/2001CA2404439A1 Diphenyl ether compounds useful in therapy
10/04/2001CA2404411A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
10/04/2001CA2404172A1 Antiprogestins with partial agonist activity
10/04/2001CA2403857A1 Anti-angiogenic and anti-tumor properties of matin and other laminin domains
10/04/2001CA2403800A1 Beta-like glycoprotein hormone polypeptide and heterodimer
10/04/2001CA2403787A1 Il-8 receptor antagonists
1 ... 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 ... 557